Wellbeing Digital Sciences Inc KONEF

$MEDI-Ketamine One

[maysilverstone]

With nearly 1 in 5 Americans living with a mental illness or addiction problem in 2019, psychedelic's are becoming increasingly popular with the psychedelic drug market expected to reach over $10B by 2027.
 

A company that recently came across my radar is Ketamine One, a wellness company focused on ketamine-assisted therapies and psychedelic medicines.
 

Here's a quick overview:
- 16 clinics across North America with 3 under LOI. Target expansion to 30 clinics
- 90+ clinicians and educators working across their current clinic portfolio
- $3.5M 2020E rev for the clinic portfolio
- $6M expected 2021 rev
- Unifor partnership to further grow eHealth and telemedicine implementation

- Utilizing a wearable device to track patient vitals before, during, and after psychedelic-assisted therapies

Here's the link to the investors page on their website to learn more: https://www.ketamine.one/investor-relations